656 related articles for article (PubMed ID: 36116070)
21. Evaluating COVID-19 vaccine hesitancy: A qualitative study from Vietnam.
Duong MC; Nguyen HT; Duong M
Diabetes Metab Syndr; 2022 Jan; 16(1):102363. PubMed ID: 34922216
[TBL] [Abstract][Full Text] [Related]
22. Analysis of Perception, Reasons, and Motivations for COVID-19 Vaccination in People with Diabetes across Sub-Saharan Africa: A Mixed-Method Approach.
Osuagwu UL; Langsi R; Ovenseri-Ogbomo G; Mashige KP; Abu EK; Envuladu EA; Goson PC; Ekpenyong BN; Oloruntoba R; Miner CA; Charwe DD; Timothy CG; Ishaya T; Amiebenomo OM; Lim D; Agho KE
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805551
[TBL] [Abstract][Full Text] [Related]
23. Demographic factors associated with acceptance, hesitancy, and refusal of COVID-19 vaccine among residents of Sukkur during lockdown: A cross sectional study from Pakistan.
Samo AA; Sayed RB; Valecha J; Baig NM; Laghari ZA
Hum Vaccin Immunother; 2022 Dec; 18(1):2026137. PubMed ID: 35103572
[TBL] [Abstract][Full Text] [Related]
24. Determinants of COVID-19 vaccine hesitancy and uptake in sub-Saharan Africa: a scoping review.
Deml MJ; Githaiga JN
BMJ Open; 2022 Nov; 12(11):e066615. PubMed ID: 36400736
[TBL] [Abstract][Full Text] [Related]
25. Determinants of COVID-19 Vaccine Hesitancy: A Cross-Sectional Study on a Mexican Population Using an Online Questionnaire (COV-AHQ).
Delgado-Gallegos JL; Padilla-Rivas GR; Zúñiga-Violante E; Avilés-Rodríguez G; Arellanos-Soto D; Gastelum-Arias LJ; Franco Villareal H; Cosío-León MLÁ; Romo-Cardenas GS; Moreno-Treviño MG; Moreno-Cuevas JE; Islas JF
Front Public Health; 2021; 9():728690. PubMed ID: 34900890
[TBL] [Abstract][Full Text] [Related]
26. COVID-19 Vaccine Acceptance and Uptake in Bangkok, Thailand: Cross-sectional Online Survey.
Remmel C; Tuli G; Varrelman TJ; Han AR; Angkab P; Kosiyaporn H; Netrpukdee C; Sorndamrih S; Thamarangsi T; Brownstein JS; Astley CM
JMIR Public Health Surveill; 2023 Apr; 9():e40186. PubMed ID: 36811852
[TBL] [Abstract][Full Text] [Related]
27. Vaccine hesitancy: Beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students.
Saied SM; Saied EM; Kabbash IA; Abdo SAE
J Med Virol; 2021 Jul; 93(7):4280-4291. PubMed ID: 33644891
[TBL] [Abstract][Full Text] [Related]
28. Exploring the beliefs and experiences with regard to COVID-19 vaccine hesitancy and acceptance in a slum of Karachi, Pakistan.
Qasim R; Shah H; Sultan A; Yaqoob M; Haroon R; Mistry SK; Bestman A; Yousafzai MT; Yadav UN
Health Promot Int; 2022 Dec; 37(6):. PubMed ID: 36300701
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study.
Wu J; Li Q; Silver Tarimo C; Wang M; Gu J; Wei W; Ma M; Zhao L; Mu Z; Miao Y
Front Immunol; 2021; 12():781161. PubMed ID: 34912346
[TBL] [Abstract][Full Text] [Related]
30. Hope as a predictor for COVID-19 vaccine uptake in the US: a cross-sectional survey of 11,955 adults.
Adam M; Mohan D; Forster S; Chen S; Gates J; Yu F; Bärnighausen T
Hum Vaccin Immunother; 2022 Nov; 18(5):2072138. PubMed ID: 35659447
[TBL] [Abstract][Full Text] [Related]
31. Vaccine hesitancy against COVID-19 vaccine over time in Nigeria.
Sato R
Vaccine; 2023 Apr; 41(17):2749-2753. PubMed ID: 36959055
[TBL] [Abstract][Full Text] [Related]
32. Factors influencing COVID-19 vaccine uptake among adults in Nigeria.
Adedeji-Adenola H; Olugbake OA; Adeosun SA
PLoS One; 2022; 17(2):e0264371. PubMed ID: 35202444
[TBL] [Abstract][Full Text] [Related]
33. A cross-sectional analysis of the predictors of COVID-19 vaccine uptake and vaccine hesitancy in Iraq.
Alatrany SSJ; Falaiyah AM; Zuhairawi RHM; Ogden R; ALi Sayyid ALdrraji H; Alatrany ASS; Al-Jumeily D
PLoS One; 2023; 18(3):e0282523. PubMed ID: 36893102
[TBL] [Abstract][Full Text] [Related]
34. COVID-19 vaccine hesitancy and resistance in an urban Chinese population of Hong Kong: a cross-sectional study.
Yu BY; Lam JC; Lam SC; Li Y; Chen S; Lam MY; Yeung WF
Hum Vaccin Immunother; 2022 Nov; 18(5):2072144. PubMed ID: 35612813
[TBL] [Abstract][Full Text] [Related]
35. The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal.
Chan NN; Ong KW; Siau CS; Lee KW; Peh SC; Yacob S; Chia YC; Seow VK; Ooi PB
BMC Public Health; 2022 Feb; 22(1):296. PubMed ID: 35164734
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 vaccination intention and hesitancy: Mistrust on COVID-19 vaccine benefit a major driver for vaccine hesitancy among healthcare workers; a cross-sectional study in North India.
Jose S; Cyriac MC; Dhandapani M; Joseph J
J Prev Med Hyg; 2022 Jun; 63(2):E219-E230. PubMed ID: 35968070
[TBL] [Abstract][Full Text] [Related]
37. Assessment of the impact of the vaccine pass policy on COVID-19 vaccine hesitancy and uptake among Chinese adults in Hong Kong.
Wong IOL; Wong C; Mak N; Dai A; Xiao J; Wu P; Ni MY; Liao Q; Cowling BJ
Vaccine; 2024 May; 42(14):3346-3354. PubMed ID: 38627146
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines?
Cooper S; van Rooyen H; Wiysonge CS
Expert Rev Vaccines; 2021 Aug; 20(8):921-933. PubMed ID: 34252336
[No Abstract] [Full Text] [Related]
39. Examining confidence and hesitancy towards COVID-19 vaccines: A cross-sectional survey using in-person data collection in rural Ghana.
Afreh OK; Angwaawie P; Attivor E; Boateng LA; Brackstone K; Head MG; Manyeh AK; Vidzro G
Vaccine; 2023 Mar; 41(13):2113-2119. PubMed ID: 36822965
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 Vaccine-Related Attitudes and Beliefs in Canada: National Cross-sectional Survey and Cluster Analysis.
Benham JL; Atabati O; Oxoby RJ; Mourali M; Shaffer B; Sheikh H; Boucher JC; Constantinescu C; Parsons Leigh J; Ivers NM; Ratzan SC; Fullerton MM; Tang T; Manns BJ; Marshall DA; Hu J; Lang R
JMIR Public Health Surveill; 2021 Dec; 7(12):e30424. PubMed ID: 34779784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
